Neurotune Overview

  • Founded
  • 2005
Founded
  • Status
  • Private
  • Employees
  • 11
Employees
  • Latest Deal Type
  • Angel
  • Investors
  • 4

Neurotune General Information

Description

Owner and operator of a Swiss bio-pharmaceutical company. The company develops small molecules into potential drugs and offers them as medications and diagnostics for unmet medical needs in neuron-muscular, renal indications and to treat neurological disorders.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Other Pharmaceuticals and Biotechnology
Primary Office
  • Wagistrasse 27 a
  • Schlieren
  • 8952 Zurich
  • Switzerland
+41 044 000 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Neurotune Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Angel (individual) 29-Jul-2008 00.00 Completed Startup
4. Seed Round 13-Apr-2007 00.000 00.00 0000 Completed Startup
3. Seed Round 17-Jul-2006 00.000 00.000 00.000 Completed Startup
2. Seed Round 23-Dec-2005 $1.07M $1.07M 00.000 Completed Startup
1. Angel (individual) Completed Startup
To view Neurotune’s complete valuation and funding history, request access »

Neurotune Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary 000,000 00.00 00.00 00 00.00 00.000
Ordinary 0,000,000 00.00 00.00 00 00.00 00.000
To view Neurotune’s complete cap table history, request access »

Neurotune Executive Team (3)

Name Title Board Seat Contact Info
Bruno Oesch Ph.D Co-Founder & Executive Chairman
You’re viewing 1 of 3 executive team members. Get the full list »

Neurotune Board Members (2)

Name Representing Role Since
Armin Mäder Ph.D Self Board Member 000 0000
Katja Berlinger JD Neurotune Board Member 000 0000
To view Neurotune’s complete board members history, request access »

Neurotune Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Neurotune Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Prionics Minority 000 0000 000000 0
Private Equity Invest Other Minority 000 0000 000000 0
Zürcher Kantonalbank Corporation Minority 000 0000 000000 0
BioBac Angel Group Minority 000 0000 000000 0
To view Neurotune’s complete investors history, request access »